http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020205204-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d7ecc3870e4505732085fb7694bab4d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2020-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2ab74488bebd3e4937581f429730c19 |
publicationDate | 2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020205204-A1 |
titleOfInvention | Methods for the detection of prostate cancer |
abstract | Aspects of the disclosure relate to methods and systems for detecting prostate cancer and/or evaluating a subject for a prostate biopsy. In some embodiments, a subject may undergo an assessment to determine the likelihood of prostate cancer. For instance, one or more immunoassay may be performed on a blood sample of the subject to determine biomarker levels that may be used with certain clinical factors to determine a likelihood score for aggressive prostate cancer. A subject having a likelihood score within a threshold range may undergo a second assessment to determine the likelihood of prostate cancer. For example, the subject may undergo an imaging technique to detect prostate cancer. The outcome of the second assessment may be used to determine the likelihood of aggressive prostate cancer and/or biopsy recommendation. Methods and systems, described herein, may be particularly well-suited for the minimally invasive and cost-effective detection of prostate cancer in subjects. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020395123-A1 |
priorityDate | 2019-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 504.